Gastrointestinal: Diarrhea (overall, greater than 1%; Helicobacter pylori therapy, 7% to 8%), Nausea (> 1%), Vomiting (> 1%).
Neurologic: Headache (Helicobacter pylori therapy, 6% to 7%).
Reproductive: Vulvovaginitis.
Serious: Dermatologic: Erythema multiforme, Stevens-Johnson syndrome, Toxic epidermal necrolysis.
Gastrointestinal: Clostridium difficile diarrhea.
Immunologic: Anaphylaxis, Hypersensitivity reaction.
View ADR Reporting Link
Sign Out